← All companies
AMRX annual net income
Amneal Pharmaceuticals, Inc.
AMRX - CIK 0001723128
Market cap$4.89 B
Rank#1397
SEC filings664
Amneal Pharmaceuticals, Inc. net income by year
Amneal Pharmaceuticals, Inc. (AMRX) reported net income of $72.06M for fiscal year 2025, as filed in its audited annual report with the SEC.
AMRX net income 2016-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $72.06M | +161.6% |
| FY 2024 | -$116.89M | -39.2% |
| FY 2023 | -$83.99M | +69.0% |
| FY 2022 | -$270.58M | -2155.6% |
| FY 2021 | $13.16M | -80.6% |
| FY 2020 | $67.79M | +111.2% |
| FY 2019 | -$603.57M | -2957.0% |
| FY 2018 | -$19.74M | - |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Amneal Pharmaceuticals, Inc. make?
Amneal Pharmaceuticals, Inc. (AMRX) reported net income of $72.06M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Amneal Pharmaceuticals, Inc.'s net income changed over time?
Between fiscal 2016 and fiscal 2025, Amneal Pharmaceuticals, Inc.'s net income grew from $0.00 to $72.06M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.